Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, 14-Day, Double-blind, Randomized, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Tolperisone in Subjects With Pain Due to Acute Back Muscle Spasm

NCT04671082 is registered in ClinicalTrials.gov with Neurana Pharmaceuticals, Inc. as lead sponsor.

NCT NCT04671082
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04671082 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, 14-Day, Double-blind, Randomized, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Tolperisone in Subjects With Pain Due to Acute Back Muscle Spasm
Lead sponsor
Neurana Pharmaceuticals, Inc.
Phase
Phase 3
Overall status
Completed
Start date
December 15, 2020
Completion date
March 21, 2022
Enrollment
1,004 (actual)
Sites
56

Conditions

As the registry lists them; a condition with its own page is linked.

acute pain, back muscle spasm, back pain, back spasm upper, back strain, muscle spasm